World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 1 April 2019
Main ID:  ISRCTN48802295
Date of registration: 10/07/2017
Prospective Registration: No
Primary sponsor: Charité University Medicine Berlin
Public title: Comparison of different techniques regarding visualization of scars in the heart muscle using cardiac MRI
Scientific title: Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical trial
Date of first enrolment: 01/11/2014
Target sample size: 302
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN48802295
Study type:  Observational
Study design:  Observational cohort study (Diagnostic)  
Phase:  Not Applicable
Countries of recruitment
Germany
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Jeanette    Schulz-Menger
Address:  Charité University Medicine Berlin Campus Buch Working Group Kardiale MRT Lindenberger Weg 80 13125 Berlin Germany
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Known or suspected chronic myocardial infarction, hypertrophic cardiomyopathy or inflammatory heart disease
2. Clinical indication for MR exam with late gadolinium enhancement
3. Age range =18 years (no upper limit)

Exclusion criteria:
1. Any contraindication for MR exam
2. Acute or chronic renal failure with GFR <30ml/min


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Myocardial infarction, hypertrophic cardiomyopathy and inflammatory heart disease
Circulatory System
Intervention(s)

This is an observational study in which three different techniques are compared for visualization of myocardial fibrosis using late Gadolinium enhancement in patients with known or suspected cardiomyopathy.

Patients sent for clinically indicated cardiac LGE-based MRI with known or suspected LGE due to chronic infarction, inflammatory myocardial disease and hypertrophic cardiomyopathy (HCM) are prospectively recruited. The indication for the MRI itself is clinical. However, for this study the MRI protocol is extended by the tested multislice LGE sequences for approximately 5 extra minutes. LGE images are acquired using three different LGE sequences. All patients were scanned with all three LGE sequences (intraindividual comparison). All LGE sequences are then assessed as follows: image quality is evaluated with a 4-point scoring system. Contrast-to-noise ratios and acquisition time are measured. Size of LGE is quantitatively assessed using a semi-automated threshold method. All assessments are done by blinded readers.
Primary Outcome(s)
Size of myocardium with late Gadolinium enhancement in each tested MR sequence, measured by semiautomated threshold method in MRI DICOM data at one timepoint, the date of the MRI (no follow up)
Secondary Outcome(s)

1. Contrast-to-noise ratio in each tested MR sequence, measured using MRI DICOM data
2. Image quality, scored on a 4-point-scaling system based on visual assessment by blinded readers
Measured at at one timepoint, the date of the MRI (no follow up)
Secondary ID(s)
LGE COMPARE (internal study code)
Source(s) of Monetary Support
Charité Universitätsmedizin Berlin
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics board at Charité University Medicine Berlin, Campus Mitte, 16/10/2014, ref: EA1/305/14
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2016
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history